Share on LinkedInShare on LinkedIn

ARTICLE · 30 SEPTEMBER 2019

Bayer Awarded Injunction, RMB1.31 Million In Syringe Patent Case

Both Bayer and Bangshengdel accepted the first-instance judgment.

ChinaIntellectual Property

Bayer Health Care Company sued Shenzhen Ante High-Tech Indus-trial Company, Beijing Bangshengdel Trading Company for invention patent infringement. Recently, Beijing Higher People's Court made a final judgment on the case, ordering Ante to immediately stop manufacturing, offering to sell, selling the alleged infringing products and to destroy the drawings and molds for the manufacture of the alleged infringing products and indem-nify1.31 million yuan in damages and reasonable costs and ordering Bangshengdel to immediately ceased selling the alleged infringing products.

Bayer is the patent right holder of "front-loading medical injectors and syringes, syringe interfaces, syringe adapters and syringe plungers for their use" (Patent Number: ZL00817905.0). The company found the products called "one- time use of high- pressure contrast syringes and accessories" (alleged infringing products) produced by Ante and sold by Bangshengdel fell within the scope of the claimed

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

AFD China Newsletter is intended to provide our clients and business partners information only. The information provided on the newsletter should not be considered as professional advice, and should not form the basis of any business decisions.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from